Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection

Gut

Volumn 60, Issue 11, 2011, Pages 1563-1571

  Fitzmaurice, Karen ^a,b   Petrovic, Danijela ^a   Ramamurthy, Narayan ^b   Simmons, Ruth ^b   Merani, Shazma ^d   Gaudieri, Silvana ^c,d   Sims, Stuart ^b   Dempsey, Eugene ^a   Freitas, Elizabeth ^c   Lea, Susan ^e   McKiernan, Susan ^a   Norris, Suzanne ^a   Long, Aideen ^a   Kelleher, Dermot ^a   Klenerman, Paul ^b,f  

^a ST JAMES S HOSPITAL   (Ireland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MURDOCH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; HLA A ANTIGEN; LYSINE; THREONINE;

ALLELE; AMINO ACID SUBSTITUTION; ANTIGEN FUNCTION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC ANALYSIS; HEPATITIS C; HUMAN; HUMAN CELL; IRELAND; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPLICON; SEQUENCE ANALYSIS; VIRAL CLEARANCE; VIRUS MUTANT; VIRUS MUTATION;

ADULT; ALLELES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DNA FOOTPRINTING; ELECTROPORATION; EPITOPES, T-LYMPHOCYTE; FEMALE; GENETIC FITNESS; HEPATITIS C; HLA-A3 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; PROTEIN BIOSYNTHESIS; SEQUENCE ALIGNMENT;

EID: 80053566559     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.228403     Document Type: Article

References (39)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52. (Pubitemid 32634271)
2. Bowen DG, Walker CM. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 2005;201:1709-14. (Pubitemid 41002889)
3. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005;436:946-52. (Pubitemid 41191670)
4. Thimme R, Bukh J, Spangenberg HC, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 2002;99:15661-8. (Pubitemid 35403988)
5. Grakoui A, Shoukry NH, Woollard DJ, et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003;302:659-62. (Pubitemid 37310924)
6. Shoukry NH, Grakoui A, Houghton M, et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003;197:1645-55. (Pubitemid 36745340)
7. McKiernan SM, Hagan R, Curry M, et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004;40:108-14. (Pubitemid 38877575)
8. Timm J, Lauer GM, Kavanagh DG, et al. CD8 epitope escape and reversion in acute HCV infection. J Exp Med 2004;200:1593-604. (Pubitemid 40094183)
9. Neumann-Haefelin C, McKiernan S, Ward S, et al. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 2006;43:563-72.
10. Crawford H, Prado JG, Leslie A, et al. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol 2007;81:8346-51. (Pubitemid 47101520)
11. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004;432:769-75.
12. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999;340:1228-33. (Pubitemid 29181642)
13. Ward S, Lauer G, Isba R, et al. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin Exp Immunol 2002;128:195-203. (Pubitemid 34534031)
14. Itakura J, Nagayama K, Enomoto N, et al. Viral load change and sequential evolution of entire hepatitis C virus genome in Irish recipients of single source-contaminated anti-D immunoglobulin*. J Viral Hepat 2005;12:594-603. (Pubitemid 41532490)
15. Krieger N, Lohmann V, Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 2001;75:4614-24. (Pubitemid 32381503)
16. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000;6:578-82. (Pubitemid 30305910)
17. th edn: Blackwell Publishing, London, UK; 2006.
18. Leslie AJ, Pfafferott KJ, Chetty P, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004;10:282-9. (Pubitemid 38667619)
19. Martinez-Picado J, Prado JG, Fry EE, et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 2006;80:3617-23.
20. Schneidewind A, Brockman MA, Yang R, et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 2007;81:12382-93. (Pubitemid 350085852)
21. Salloum S, Oniangue-Ndza C, Neumann-Haefelin C, et al. Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs. J Virol 2008;82:11803-12.
22. Bartenschlager R. The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy. J Viral Hepat 1999;6:165-81. (Pubitemid 29260100)
23. Soderholm J, Ahlen G, Kaul A, et al. Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 2006;55:266-74. (Pubitemid 43117288)
24. Brockman MA, Schneidewind A, Lahaie M, et al. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol 2007;81:12608-18. (Pubitemid 350085874)
25. Dazert E, Neumann-Haefelin C, Bressanelli S, et al. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. J Clin Invest 2009;119:376-86.
26. Venkatraman S, Wu W, Prongay A, et al. Potent inhibitors of HCV-NS3 protease derived from boronic acids. Bioorg Med Chem Lett 2009;19:180-3.
27. Wong DK, Dudley DD, Dohrenwend PB, et al. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J Virol 2001;75:1229-35. (Pubitemid 32094682)
28. Cox AL, Mosbruger T, Lauer GM, et al. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 2005;42:104-12. (Pubitemid 40911317)
29. Timm J, Li B, Daniels MG, et al. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 2007;46:339-49. (Pubitemid 47344768)
30. Gaudieri S, Rauch A, Park LP, et al. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol 2006;80:11094-104. (Pubitemid 44706550)
31. Rauch A, James I, Pfafferott K, et al. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology 2009;50:1017-29.
32. Neumann-Haefelin C, Timm J, Schmidt J, et al. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope. Hepatology 2010;51:54-62.
33. Yee LJ. Host genetic determinants in hepatitis C virus infection. Genes Immun 2004;5:237-45. (Pubitemid 38967177)
34. Wang JH, Zheng X, Ke X, et al. Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol J 2009;6:46.
35. Yoon SK, Han JY, Pyo CW, et al. Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population. Liver Int 2005;25:1122-7. (Pubitemid 41782554)
36. Thio CL, Thomas DL, Karacki P, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003;77:12083-7. (Pubitemid 37345173)
37. Komatsu H, Lauer G, Pybus OG, et al. Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes. J Viral Hepat 2006;13:121-30.
38. Ray SC, Fanning L, Wang XH, et al. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 2005;201:1753-9. (Pubitemid 41002894)
39. Merani S, Petrovic D, James I, et al. Effect of immune pressure on hepatitis C virus evolution: Insights from a single-source outbreak. Hepatology 2011;53:396-405.